ArticleInternational journal of molecular sciences2022

Development of a Novel Anti-CD44 Monoclonal Antibody for Multiple Applications against Esophageal Squamous Cell Carcinomas.

Nohara Goto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.